Clinical Trials Browser

Phase 2 × Pancreatic Cancer Non-resectable × irinotecan sucrosofate × Clear all

NCT05047991 2021-09-17

Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Pancreatic Cancer Non-resectable